Jump to content

Pyeazolam

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 82.77.10.190 (talk) at 16:31, 11 July 2023 (Fixed the formatting issues. Removed the second paragraph because it didn't seem coherent - you may add it back if needed.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Pyeazolam
Identifiers
  • 8-ethynyl-1-methyl-6-(pyridin-2-yl)-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H13N5
Molar mass299.337 g·mol−1
3D model (JSmol)
  • CC1=NN=C2N1C3=C(C=C(C=C3)C#C)C(=NC2)C4=CC=CC=N4
  • InChI=1S/C18H13N5/c1-3-13-7-8-16-14(10-13)18(15-6-4-5-9-19-15)20-11-17-22-21-12(2)23(16)17/h1,4-10H,11H2,2H3
  • Key:LQKOTGTWBANJBS-UHFFFAOYSA-N

Pyeazolam (SH-TRI-108) is a triazolobenzodiazepine derivative which has been sold online as a designer drug. It has been found to be relatively selective for the α5 subtype of GABAA receptors, in a similar manner to the related compound QH-ii-066,[1] and is claimed to have an effects profile more similar to alcohol than typical benzodiazepines.

See also

References

  1. ^ Clayton T, Poe MM, Rallapalli S, Biawat P, Savić MM, Rowlett JK, et al. (2015). "A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model". International Journal of Medicinal Chemistry. 2015: 430248. doi:10.1155/2015/430248. PMC 4657098. PMID 26682068.